Whittington, R <br/><br/>
Idarubicin: a pharmacoeconomic evaluation of its use in adult patients with acute myeloid leukaemia.  [electronic resource] 

 -  PharmacoEconomics  Oct 1993 
 - 287-307 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1170-7690 
<br/><br/><label>Standard No.: </label>10.2165/00019053-199304040-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bone Marrow Transplantation--economics<br/>Cost-Benefit Analysis<br/>Cytarabine--economics<br/>Drug Therapy, Combination<br/>Drug Tolerance<br/>Economics, Pharmaceutical<br/>Formularies as Topic<br/>Health Care Costs<br/>Humans<br/>Idarubicin--economics<br/>Leukemia, Myeloid--drug therapy<br/>Middle Aged<br/>Treatment Outcome